View Older Stories View More Recent Stories

Aug 15, 2022 04:05PM SomaLogic Reports Second Quarter 2022 Financial Results
Aug 15, 2022 04:05PM SomaLogic Reports Second Quarter 2022 Financial Results
Jul 26, 2022 08:03AM Somalogic (SLGC) Acquires Palamedrix
Jul 26, 2022 08:00AM SomaLogic acquires DNA nanotechnology leader Palamedrix to develop the next-generation SomaScan® Assay
Jul 26, 2022 08:00AM SomaLogic acquires DNA nanotechnology leader Palamedrix to develop the next-generation SomaScan® Assay
Jul 25, 2022 09:00AM SomaLogic to Announce Second Quarter 2022 Financial Results
Jul 25, 2022 09:00AM SomaLogic to Announce Second Quarter 2022 Financial Results
Jun 13, 2022 08:00AM SomaLogic Announces License Agreement with OncoHost for the Development of Precision Cancer Diagnostics
Jun 13, 2022 08:00AM SomaLogic Announces License Agreement with OncoHost for the Development of Precision Cancer Diagnostics
Jun 1, 2022 08:30AM SomaLogic Announces June Conference Participation
Jun 1, 2022 08:30AM SomaLogic Announces June Conference Participation
May 12, 2022 04:05PM SomaLogic Reports First Quarter 2022 Financial Results
May 12, 2022 04:05PM SomaLogic Reports First Quarter 2022 Financial Results
Apr 21, 2022 04:15PM SomaLogic to Announce First Quarter 2022 Financial Results
Apr 21, 2022 04:15PM SomaLogic to Announce First Quarter 2022 Financial Results
Apr 12, 2022 04:05PM Major journal publishes landmark proteomics study demonstrating development of an unprecedented new clinical cardiovascular risk test
Apr 12, 2022 04:05PM Major journal publishes landmark proteomics study demonstrating development of an unprecedented new clinical cardiovascular risk test
Mar 29, 2022 04:10PM SomaLogic Reports Fourth Quarter and Full Year 2021 Financial Results
Mar 29, 2022 04:10PM SomaLogic Reports Fourth Quarter and Full Year 2021 Financial Results
Mar 21, 2022 08:00AM SomaLogic to provide 210 million protein measurements to EPIC researchers to better understand and predict cancer development
Mar 21, 2022 08:00AM SomaLogic to provide 210 million protein measurements to EPIC researchers to better understand and predict cancer development
Mar 1, 2022 08:00AM SomaLogic to Announce Fourth Quarter and Full Year 2021 Financial Results
Mar 1, 2022 08:00AM SomaLogic to Announce Fourth Quarter and Full Year 2021 Financial Results
Feb 25, 2022 08:00AM SomaLogic to Participate in the Cowen 42nd Annual Health Care Conference
Feb 25, 2022 08:00AM SomaLogic to Participate in the Cowen 42nd Annual Health Care Conference
Feb 4, 2022 08:00AM Somalogic (SLGC) Guides FY2022 Revenue of $105M-$110M
Feb 4, 2022 08:00AM SomaLogic Provides 2022 Revenue Guidance in Conjunction with Analyst and Investor Meeting
Feb 4, 2022 08:00AM SomaLogic Provides 2022 Revenue Guidance in Conjunction with Analyst and Investor Meeting
Feb 2, 2022 04:29PM SomaLogic to Participate in Upcoming Investor Conferences
Feb 2, 2022 04:29PM SomaLogic to Participate in Upcoming Investor Conferences
Feb 2, 2022 08:00AM SomaLogic to provide 105 million protein measurements from 15,000 samples as part of the Multi-Ethnic Study of Atherosclerosis (MESA) Study
Feb 2, 2022 08:00AM SomaLogic to provide 105 million protein measurements from 15,000 samples as part of the Multi-Ethnic Study of Atherosclerosis (MESA) Study
Jan 11, 2022 07:08AM Somalogic (SLGC) Reports Prelim FY21 Revenues of Over $79M
Jan 11, 2022 07:01AM Somalogic (SLGC) Announces Preliminary Revenue for Full Year 2021 Above Guidance Range
Jan 11, 2022 07:00AM SomaLogic Announces Preliminary Revenue for Full Year 2021 Above Guidance Range
Jan 11, 2022 07:00AM SomaLogic Announces Preliminary Revenue for Full Year 2021 Above Guidance Range
Jan 10, 2022 04:10PM SomaLogic Announces Appointment of Adam Taich as Chief Business Officer
Jan 10, 2022 04:10PM SomaLogic Announces Appointment of Adam Taich as Chief Business Officer
Jan 7, 2022 08:00AM SomaLogic Announces Analyst and Investor Meeting on February 4, 2022
Jan 7, 2022 08:00AM SomaLogic Announces Analyst and Investor Meeting on February 4, 2022
Jan 5, 2022 04:14PM Somalogic (SLGC) announces exclusive partnership with Illumina (ILMN) to develop sequencing-based proteomic solutions
Jan 5, 2022 04:10PM SomaLogic announces exclusive partnership with Illumina to develop sequencing-based proteomic solutions
Jan 5, 2022 04:10PM SomaLogic announces exclusive partnership with Illumina to develop sequencing-based proteomic solutions
Dec 30, 2021 04:30PM SomaLogic to Participate in the 40th Annual J.P. Morgan Healthcare Conference
Dec 30, 2021 04:30PM SomaLogic to Participate in the 40th Annual J.P. Morgan Healthcare Conference
Dec 9, 2021 08:00AM SomaLogic’s SomaScan® Assay used in largest proteomic study to date, bridging the gap between genomics and disease
Dec 9, 2021 08:00AM SomaLogic’s SomaScan® Assay used in largest proteomic study to date, bridging the gap between genomics and disease
Dec 2, 2021 04:10PM SomaLogic Announces Appointment of Steven Mermelstein as Senior Vice President of Corporate Strategy, Development and Mergers and Acquisitions
Dec 2, 2021 04:10PM SomaLogic Announces Appointment of Steven Mermelstein as Senior Vice President of Corporate Strategy, Development and Mergers and Acquisitions
Nov 15, 2021 07:15AM SomaLogic Reports Third Quarter 2021 Financial Results
View More Recent Stories View Older Stories